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SUMMARY – CT perfusion (CTP) is part of the initial evaluation of stroke patients, allowing dif-
ferentiation between infarcted tissue and the ischaemic penumbra and helping in the selection of 
patients for endovascular treatment. This study assessed the reliability of the qualitative evaluation 
CTP maps in defining the ischemic penumbra and identified potential pitfalls associated with this 
technique. We reviewed CTP scans of 45 consecutive patients admitted to our institution with ante-
rior circulation acute ischaemic stroke. Two neuroradiologists performed qualitative evaluations of 
cerebral blood volume (CBV) and mean transit time (MTT) maps, using 24h follow-up non-contrast 
CT as surrogate marker for the area of definitive infarct. For each slice analyzed, the area of qualita-
tive alteration in the CBV and MTT maps was classified as either being inferior, equal or superior to 
the area of infarct on the follow-up CT. Three out of 45 (7%) patients had admission CT CBV abnor-
malities larger than follow-up lesions; 34/45 (76%) patients had infarct areas smaller than initial 
MTT prolongation. In the group of patients with no recanalization 12/19 (63%) had infarct areas 
smaller than initial MTT lesion. CBV abnormality is a reliable marker for an irreversible ischaemic 
lesion, although rarely it may overestimate the ischaemic “core”, possibly due to delay in contrast 
arrival to the brain. In the majority of patients without recanalization, MTT overestimated final 
infarct areas, probably because it does not differentiate true “at risk” penumbra from benign oligae-
mia. Qualitative evaluation of CBV and MTT maps may overestimate the real ischaemic penumbra.
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Introduction
In recent years the management of acute is-
chaemic stroke has changed from a time-guided 
to a more physiologic-based approach 1. The 
cornerstone of this modification was a better 
understanding of the altered physiology and 
immediate haemodynamic changes that follow 
occlusion of a great vessel in the anterior cir-
culation, which led to the definition of two dis-
tinct regions in the affected brain: the ischae-
mic core – irreversibly injured, non-savageable 
tissue – and an area of ischaemic penumbra 
– severely hypoperfused, clinically sympto-
matic tissue that will eventually progress to 
irreversible infarct if not reperfused quickly 2,3.
Considering that final infarct volume is a 
major determinant of long-term functional out-
come in stroke patients 4,5, intra-arterial therapy 
(IAT) has emerged as one of the most promising 
weapons for rescuing ischaemic penumbra ar-
eas and improving the clinical end result. How-
ever, it has also been shown that the size of the 
pretreatment infarct core is inversely correlated 
with the chance of a good IAT response 6 and di-
rectly related to the risk of reperfusion haemor-
rhage 7. For these reasons, reliable determination 
both infarct core and ischaemic penumbra sizes 
is essential to a correct selection of patients for 
IAT and the clinical success of recanalization.
Perfusion studies have been successfully 
used to assess the infarct core and ischaemic 
penumbra and in some studies have even re-
placed the time-window as a major selection 
criterion for IAT 8-10. CT perfusion (CTP) is gain-
ing more widespread use because it is more 
widely available and less time-consuming than 
MRI and has the potential to provide similar 
information 11,12. Nevertheless, the great hetero-
geneity of CTP acquisition protocols and post-
processing software in use 13-15 has prevented 
the establishment of standardized thresholds 
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for the quantitative definition of the ischae-
mic penumbra to date. In daily clinical prac-
tice, we rely mainly on qualitative interpre-
tation of CTP maps to determine the extent 
of the infarct core, the total area of tissue “at 
risk” and the size of the ischaemic penumbra. 
The specific aims of the current study were: 
(i) to determine the reliability of the qualitative 
evaluation of CTP maps in the assessment of 
the ischaemic penumbra and (ii) to identify po-
tential pitfalls associated with this technique. 
Methods
Patient Selection
We reviewed the records of all consecutive 
patients admitted to our institution with a 
diagnosis of acute ischaemic stroke from May 
2009 to August 2013. Patients who met the fol-
lowing criteria were included in the analysis: 
1) admission CTP scanning within eight hours 
of onset; 2) CTA confirmation of large vessel 
occlusion in the anterior circulation (top of in-
ternal carotid artery, M1 and M2 segments of 
the middle cerebral artery); 3) no intravenous 
thrombolytic therapy; 4) CT follow-up imag-
ing performed between 24 to 48 hours, but not 
between three to seven days to avoid fogging 
effects and substantial oedema. Cases were ex-
cluded for poor quality of CTP acquisition (n=5) 
due to motion or truncated arterial or venous 
density curves. 
Imaging Acquisition
CTP was performed on two multidetector 
helical scanners (either 16 section BrightSpeed 
or 64 section LightSpeed; GE Healthcare, Mil-
waukee, WI, USA) as a 45-second cine series, 
beginning five seconds after power injection of 
50 mL of contrast at 4 mL/s. Image acquisition 
was every half second for the total examination. 
Imaging parameters were 80 kVp, 120 mAs, 
1-second rotation time. Coverage consisted of 
one slab positioned parallel and superior to the 
orbital roof, with the most caudal imaging ac-
quired at the level of the basal ganglia. Each 
slab consisted of four sections (16 row CT) or 
eight sections (64 row CT) 5 mm thick. 
Image Analysis
CTP maps were post-processed by using 
a standard deconvolution software package 
(CTP3 “Std,” GE Healthcare). Two neuroradi-
ologists (one of whom was blinded to the loca-
tion of the thrombus and to the reperfusion sta-
tus) carried out independent qualitative visual 
evaluations of CBV and MTT maps, using the 
follow-up non-contrast CT hypodensity area as 
a surrogate marker for the area of definitive 
infarct. For each section analyzed, the area 
of qualitative alteration in the CBV and MTT 
maps was classified as being inferior, equal or 
superior to the final infarct area on the corre-
sponding section of the follow-up CT. When the 
observers’ classifications were divergent, the 
images were reanalysed and a final consensus 
classification was achieved.  
Statistical Analysis
Descriptive statistics are presented for the 
baseline demographic data, occlusion location, 
recanalization outcome and results. Kappa sta-
tistics were calculated to assess interobserver 
agreement.
Results
We identified 45 patients eligible for analysis; 
26 (58%) were women and the mean age was 63 
years (range 20-85 years). Occlusion locations 
were as follows: ICA terminus (14 patients), 
M1 (24), M2 (7). Thirty-five patients underwent 
mechanical thrombectomy and the recanaliza-
tion status in this group was: none (TIMI score 
0) in nine patients, partial (TIMI score 1 or 2) in 
ten patients and total (TIMI 3) in 16 patients. 
The remaining ten patients did not undergo 
any kind of acute recanalization therapy.
When comparing the initial CBV abnormal-
ity to the final infarct area the interobserver 
agreement K value was 0.50 (p<0.05); three 
out of 45 patients presented final infarct areas 
smaller than the initial CBV abnormality while 
42 patients had final infarct areas similar to or 
larger than the initial CBV defect. 
Concerning the MTT vs final infarct com-
parison, the interobserver agreement K value 
was 0.86 (p<0.05); in 34 out of the 45 patients 
(76%) the final infarct area was smaller than 
the initial MTT abnormality. 
When analysing only the group of 19 pa-
tients with no recanalization (ten without any 
recanalization treatment and nine with unsuc-
cessful thrombectomy) 12 patients (63%) had 
infarct areas smaller than initial MTT prolon-
gation. 
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Discussion
Visual inspection of CTP colour maps can be 
an effective, fast and relatively simple way of 
identifying areas of core infarct and penumbra 
and may even be sufficient to guide decisions 
on intervention 10,16,17. However, this qualitative 
technique is dependent on user interpretation, 
so recognition of potential pitfalls and diagnos-
tic challenges is essential 18. 
Our results revealed that in a large majority 
of cases (93%) admission CBV lesions progressed 
to infarct areas on follow-up CT. However, we 
found three patients in whom admission CBV 
abnormalities were larger than follow-up infarct 
lesions (Figures 1 and 2), that could suggest a 
reversibility of the ischaemic cores. Schaefer et 
al. have shown that true reversibility of core le-
sions is very rare 19. In most cases, it is actually 
“pseudoreversibility” due to the use of software 
with delay-sensitive algorithms. In fact, there 
are a number of extracranial (atrial fibrillation, 
severe internal carotid artery stenosis, conges-
tive heart failure) and intracranial (extensive 
thrombus, poor collateralization) conditions 
that cause a delay in cerebral tracer bolus ar-
rival. CBV calculation is particularly sensitive 
to this delay, resulting in an overestimation of 
CBV lesion. Ultimately, overestimation of the 
ischaemic core may lead to underestimation 
of core/penumbra mismatch, unnecessarily ex-
cluding otherwise eligible patients from IAT. 
We hypothesize that this “delay-effect” ex-
plains the findings in our three patients because 
all three had clinical conditions that could ac-
count for overestimation of initial CBV lesion: 
(1) simultaneous bilateral MCA occlusions; (2) 
atrial fibrillation; (3) hypertrophic cardiomyop-
athy with paroxysmal atrial flutter. 
In order to avoid this potential pitfall, special 
attention must be paid to the inspection of ar-
terial, venous, and tissue time-density curves. 
Likewise, the use of longer acquisition times (to 
permit the full wash-in and wash-out of con-
trast) and new delay-correction software may 
help overcome this problem 15,19,20. 
MTT prolongation is generally accepted as 
the parameter that best correlates with tissue 
“at risk” of infarction 21,22. We found that in a 
majority of patients (76%) the follow-up infarct 
was smaller than the admission MTT abnor-
mality. In particular, considering only the group 
of patients with no recanalization, where one 
would expect the final infarct to approximately 
match the initial MTT lesion, we found that in 
more than half of the cases (63%) MTT overes-
timated final infarct lesion (Figures 3 and 4). 
This overestimation results from the fact that 
areas of MTT prolongation include not only true 
critical ischaemic regions (“at-risk” penumbra) 
but also hypoperfused tissue with a delay in 
contrast arrival but that is clinically silent and 
not destined for infarction – the so-called benign 
oligaemia. The concept of benign oligaemia is 
very recent and not taken into account by much 
previous literature regarding perfusion studies 
in acute stroke 23. New interesting reports sug-
gest benign oligaemia may be present even in 
patients with an initial “malignant MRI profile” 
24 and may persist in the stroke subacute stage 25. 
Figure 1  Initial CT-CBV map in a patient with acute left mid-
dle cerebral artery occlusion (M1 segment) demonstrates a 
fronto-parieto-temporal area of CBV reduction, representing 
the ischaemic core.
Figure 2  24h follow-up CT in the same patient and at the same 
level as Figure 1 reveals no major parenchymal hypodensity 
matching the CBV defect, suggesting reversibility of the is-
chaemic core.
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Kamalian et al. have shown that appropriately 
thresholded MTT maps could differentiate true 
“at-risk” penumbra destined to infarct from non-
critical benign oligaemia, but also that the spe-
cific thresholds varied with the post-processing 
technique used 23. Moreover, to our knowledge, 
visual qualitative differentiation between these 
two regions has not been demonstrated and 
might be impossible. For this reason, our results 
raise concerns if visual interpretation of MTT 
maps is actually a good marker for true “at-risk” 
tissue and if the qualitative CBV/MTT mismatch 
evaluation can create a false, overestimated, 
ischaemic penumbra, which may influence 
therapeutic decisions and the outcome of IAT. 
Potential limitations of our study include the 
relatively small number of patients identified 
with large vessel occlusion and no recanaliza-
tion. Additionally, the limited spatial coverage 
(2 cm and 4 cm slabs) may have decreased our 
power to detect more differences between CBV 
and MTT maps and the follow-up CTs. 
Furthermore, a limitation inherent to all 
stroke imaging studies is that they represent a 
snapshot in time and we did not perform any 
follow-up angiographic study to assess vascular 
recanalization, particularly in the no recanali-
zation group, which could potentially explain 
the differences between the MTT and follow-up 
CT lesions. However it has been shown that the 
probability of acute spontaneous recanalization 
after large vessels occlusion is very low 26,27.
Conclusions
Our study has shown that qualitative evalu-
ation of CTP-CBV abnormality is a reliable 
marker for an irreversible ischaemic lesion in 
the setting of acute anterior circulation vessel 
occlusion. Still, CBV overestimation of the is-
chaemic “core” is a potential pitfall to be aware 
of when assessing these studies, and it usually 
results from a delay in the arrival of contrast to 
the brain. 
Qualitative definition of CTP-MTT lesions 
seems to overestimate the final infarct area, 
even in patients with no recanalization. Visual 
interpretation of MTT maps may not be a suit-
able method to optimally identify true “at-risk” 
penumbra and to differentiate it from benign 
oligaemia. 
Further investigation is warranted for a more 
accurate determination of the volume and loca-
tion of the true ischaemic penumbra in CTP 
studies. In the future, the employment of effec-
tive, standardized perfusion imaging methods 
will probably be essential to a proper selection 
of patients for IAT and the successful manage-
ment of acute ischaemic stroke. 
↑ Figure 4  24h follow-up CT in the same patient and at the 
same level as Figure 3 demonstrates a small hypodense area 
of acute infarction at the left fronto-opercular region. No other 
areas of acute hypodensity were found in the remaining terri-
tory of the middle cerebral artery.
← Figure 3  Admission CT-MTT map in a patient with acute 
occlusion of the top of the left internal carotid artery shows 
an extensive area of MTT prolongation, representing the total 
territory of the left middle cerebral artery. The patient was 
submitted to intra-arterial thrombectomy, which failed to re-
move the thrombus.
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